Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice

Molecular Medicine Reports
Qi YuSiwang Wang

Abstract

Low‑density lipoprotein receptors (LDLRs) may serve a role in the diabetogenic effect of statins; however, the effects of statins on LDLR expression and its regulation in the pancreas and islets have yet to be determined. To exclude the long‑term effects of treatment with atorvastatin, which allows mice to adapt, male C57BL/j and apolipoprotein E‑deficient mice were acutely treated with oral atorvastatin for 6 weeks, and glucose homeostasis and LDLR expression in the pancreas and islets were examined. In the present study, it was observed that the short‑term use of atorvastatin affected insulin sensitivity in normal mice and glucose tolerance in hyperlipidemic mice. Furthermore, it was identified that 6 weeks of treatment with atorvastatin suppressed LDLR expression in the pancreas and pancreatic islets in C57BL/j mice, and an increase in proprotein convertase subtilisin/kexin type 9 expression was additionally observed in the pancreas. However, 6 weeks of treatment with atorvastatin did not affect LDLR expression in the pancreas of hyperlipidemic mice. It may be concluded that the short‑term use of atorvastatin disturbs glucose homeostasis and suppresses LDLR expression in the pancreas and pancreatic islets in C57BL/j mice, su...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 2, 2005·Cell Metabolism·Alan D Attie, Nabil G Seidah
Feb 5, 2008·The Journal of Clinical Investigation·Liam R BrunhamMichael R Hayden
Oct 31, 2009·Nature Protocols·Dong-Sheng LiLong-Jun Dai
Jul 9, 2011·Cardiovascular Diabetology·Sameer AnsarPeter D Reaven
Feb 14, 2012·Molecular Biology Reports·Qi YuEnqi Liu
Jul 24, 2012·Atherosclerosis. Supplements·Naveed Sattar, Marja-Riitta Taskinen
Jan 10, 2013·Current Atherosclerosis Reports·Kelly AxsomArthur Z Schwartzbard
Feb 6, 2013·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Ellen C Jensen
Jan 1, 2014·Diabetes, Obesity & Metabolism·A M van den HoekH M G Princen
Mar 20, 2014·Metabolism: Clinical and Experimental·Marilyne BraultStella S Daskalopoulou
Dec 3, 2014·Cell Metabolism·Cynthia HongPeter Tontonoz
Mar 11, 2015·JAMA : the Journal of the American Medical Association·Joost BesselingG Kees Hovingh
Mar 31, 2015·Cell·Joseph L Goldstein, Michael S Brown
Jun 10, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Daxin ChengEnqi Liu
Jul 16, 2015·BMC Complementary and Alternative Medicine·Sun Haeng ParkHo Kyoung Kim
Aug 1, 2015·British Journal of Pharmacology·Frédéric CapelBéatrice Morio
Sep 4, 2015·Current Protocols in Pharmacology·Brian L Furman
Dec 10, 2015·Drug Design, Development and Therapy·Wang Zhao, Shui-Ping Zhao
Aug 28, 2016·Biochemical and Biophysical Research Communications·Sungwon LeeKyungjae Kim
Jan 17, 2017·The American Journal of Medicine·Charles H HennekensMarc A Pfeffer
Feb 20, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jing LiangYu Liu
Jul 1, 2017·Frontiers in Pharmacology·Qi YuCang-Bao Xu

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR

Software Mentioned

SPSS
ImageJ

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.